Marché mondial des systèmes d’injection sans aiguille – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse du marché et de la taille des systèmes d'injection sans aiguille

Les systèmes d'injection sans aiguille sont utilisés pour administrer des préparations liquides, des médicaments et des vaccins aux patients sans percer la peau avec une aiguille conventionnelle. La demande pour ces systèmes a considérablement augmenté ces dernières années car ils améliorent la réponse immunitaire aux vaccins , éliminent les risques liés aux aiguilles et réduisent les coûts des soins de santé.

Data Bridge Market Research analyse que le marché des systèmes d’injection sans aiguille, qui était de 156,00 millions USD en 2022, devrait atteindre 670,77 millions USD d’ici 2030 et devrait connaître un TCAC de 20,00 % au cours de la période de prévision. Cela indique la valeur marchande. Les injecteurs sans aiguille à base de liquide dominent le segment de type du marché des systèmes d’injection sans aiguille en raison de la demande croissante d’administration de médicaments. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l’épidémiologie des patients, l’analyse du pipeline, l’analyse des prix et le cadre réglementaire.

Portée et segmentation du marché des systèmes d'injection sans aiguille

Définition du marché

Les systèmes d'injection sans aiguille sont utilisés pour administrer des formulations liquides, des médicaments et des vaccins aux patients sans percer la peau avec une aiguille conventionnelle. La demande pour ces systèmes a considérablement augmenté ces dernières années car ils améliorent la réponse immunitaire aux vaccins, éliminent les risques liés aux aiguilles et réduisent les coûts des soins de santé. Cependant, le manque de professionnels qualifiés et l'utilisation restreinte des systèmes d'injection sans aiguille pour l'administration intraveineuse freinent la croissance du marché.

Dynamique du marché mondial des systèmes d'injection sans aiguille

Conducteurs

• Prévalence croissante des patients et promotion du traitement pour stimuler la croissance du marché

Les médicaments sont censés être administrés dans le corps sans utiliser d'aiguille d'injection de la manière la plus pratique et la plus indolore possible. Les systèmes d'injection sans aiguille sont utilisés pour administrer des médicaments pour le traitement de nombreuses pathologies différentes. On estime qu'au cours de la période de prévision, la valeur du marché des systèmes d'injection sans aiguille augmentera en raison de la prévalence accrue de maladies chroniques, notamment l'ostéoporose et le diabète.

Les systèmes d'injection sans aiguille sont de nouveaux moyens d'introduire divers médicaments dans les patients sans percer la peau avec une aiguille conventionnelle.

• Compétences en recherche et développement

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to medical devices and advance products will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical instruments is also expected to drive the market growth rate.

When developing drug-delivery device systems, it is important to identify equipment that can efficiently perform all of the required product testing while intelligently capturing and evaluating the test data in accordance with government regulations. The test system must also be flexible and modular enough that manufacturers can change and add functionality over time.

• Increasing Government Initiatives for Improving Healthcare

Healthcare sector is increasing rapidly, which have a significant impact on public health as well as economic activity. The increasing government initiatives for advance systems enhance the demand for the Needle Free Injection Systems. The use of Needle Free Injection Systems is increasing in households, hospitals and independent laboratory.

When developing and mass producing such devices, manufacturers usually perform a combination of testing to government-regulated standards and internal quality testing to ensure efficacy of the device. Internal quality testing is often necessary because the international standards committees cannot always amend testing standards as quickly as the device technology evolves.

Opportunities

• Increasing Demand for Painless Drug Delivery

Needle-free injections provide a painless alternative to traditional needle injections, which can be particularly beneficial for patients who have a fear of needles or experience discomfort during injections. The market is expected to grow as more individuals seek painless drug delivery options.

• Expansion of Vaccination Programs

Needle-free injection systems are also being widely adopted in vaccination programs, particularly in developing countries. They offer advantages such as reduced cross-contamination risk and improved vaccine coverage. As global vaccination programs continue to expand, the demand for needle-free injection devices is expected to rise.

Restraints/Challenges

• Limited Awareness and Acceptance

The needle-free injection technology is still relatively new and not as widely known or accepted compared to traditional needle injections. Healthcare providers and patients may have concerns about the efficacy, safety, and reliability of these devices, which could hinder their adoption.

• High Cost of Products

Needle-free injection devices can be more expensive compared to traditional needle-based injection systems. The initial investment and ongoing maintenance costs associated with these devices may limit their adoption, particularly in low-income regions or healthcare settings with budget constraints.

This Needle Free Injection Systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global needle free injection systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In March 2022, NovaXS Biotech launch injection therapy needle-free such as NovaXS Biotech wants to make injection therapy needle-free
• In December 2021, PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next-generation DNA-based COVID-19 vaccine candidates
• In August 2021, PharmaJet partner Zydus Cadila announced Emergency Use Authorization approval for worlds first plasmid DNA COVID-19 vaccine deliver via needle-free injection

Global Needle Free Injection Systems Market Scope

The Needle Free Injection Systems market is segmented on the type, product, technology, usability, site of delivery, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Liquid-Based Needle-Free Injectors
• Projectile/Depot-Based Needle-Free Injectors
• Powder-Based Needle Free Injectors

Product

• Fillable Needle-Free Injectors
• Prefilled Needle-Free Injectors

Technology

• Jet-Based Needle-Free Injectors
• Spring Global Needle Free Injectors
• Laser-Powered Needle-Free Injectors
• Vibration-Based Needle-Free Injectors

Usability

• Disposable Needle-Free Injectors
• Reusable Needle-Free Injectors

Site of Delivery

• Subcutaneous Injectors
• Intramuscular Injectors
• Intradermal Injectors

Application

• Vaccine Delivery
• Insulin Delivery
• Oncology​​​​​​​
• Pain Management
• Other

End User

• Hospitals and Clinics
• Home Care Settings
• Research Laboratories
• Pharmaceutical and Biotechnological Companies
• Other

Global Needle Free Injection Systems Market Regional Analysis/Insights

The global Needle Free Injection Systems market is analysed and market size insights and trends are provided by country, type, product, technology, usability, site of delivery, application and end user as referenced above.

The countries covered in the Needle Free Injection Systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the global needle free injection systems market because of the strong base of healthcare facilities, the strong presence of major players in the market increases cases of chronic diseases, and the rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global needle free injection systems market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global needle free injection systems market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global needle free injection systems market. The data is available for the historic period 2015-2020.

Competitive Landscape and Global Needle Free Injection Systems Market Share Analysis

Le paysage concurrentiel du marché mondial des systèmes d'injection sans aiguille fournit des détails sur les concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché mondial des systèmes d'injection sans aiguille.

Certains des principaux acteurs opérant sur le marché mondial des systèmes d’injection sans aiguille sont :

• PharmaJet (États-Unis)
• Instruments de portail (États-Unis)
• Medical International Technology, Inc (États-Unis)
• Dispositifs médicaux NuGen (Canada)
• Crossject SA (États-Unis)
• Antares Pharma (États-Unis)
• 3M (États-Unis)
• Injex Pharma AG (Allemagne)
• NovaXS Biotech (États-Unis)
• INVIO Pharmaceutical Inc. (États-Unis)

SKU-21353